Is rigevidon a good contraceptive pill?

Is rigevidon a good contraceptive pill?

Rigevidon is an effective generic combined contraceptive pill. It’s the generic version of Microgynon. When taken correctly it’s 99% effective.

Does rigevidon put weight on you?

The rigevidon pill has been linked to weight gain, depression, and an increased risk of blood clots.

What are the side effects of rigevidon?

What are the side effects of Rigevidon?

  • Feeling sick.
  • Abdominal pain.
  • Headache.
  • Breast pain or tenderness.
  • Slight bleeding or spotting between periods in the first few months.
  • Lighter periods or sometimes stopping of periods.
  • Mood changes. However, there’s no evidence that the pill causes depression.
  • Fluid retention.

What generation of pill is rigevidon?

2nd generation contraceptive pills: Anastrella®, Cilest®, Ethinylestradiol/levonorgestrel “Copharma”, Etnor, Femicept, Loette® 28, Microgyn®, Microstad, Rigevidon.

Can you get pregnant on rigevidon?

When taken correctly, Rigevidon is over 99% effective in preventing pregnancy. In reality, this is closer to 91% because missing pills, being sick, diarrhoea and taking certain other medicines can make Rigevidon less effective.

Will rigevidon stop my period?

Most combined contraceptive pills can be taken back-to-back to delay your period, including Microgynon, Rigevidon, Cilest and Yasmin. Phasic pills, however, contain different quantities of hormones in each pill, and you should consult your doctor before taking more than one packet in succession.

Will rigevidon help my acne?

The Rigevidon pill does improve acne for a number of users, but it’s important to remember that it affects everyone differently so you aren’t guaranteed a positive change. Taking the combined pill may also cause acne to worsen initially when you start taking it.

Which combined pill has lowest risk of blood clots?

“Oral contraceptives with levonorgestrel and a low dose of estrogen are associated with the lowest risk of venous thrombosis [blood clots] and are therefore the safest option,” says Astrid van Hylckama Vlieg, PhD, a research fellow at Leiden University Medical Center in the Netherlands, and the lead author of one study …